On December 3, 2020, Taiwan Food and Drug Administration (TFDA) released a draft list of prohibited ingredients in cosmetics for public consultation. Any suggestions on the list can be mailed to sherrycty@fda.gov.tw until Feb 1, 2021.
The list is scheduled to come into effect from July 1, 2021. From that date, it is prohibited to manufacture, import, selling, supply or display cosmetics containing the ingredients in the list.
Compared with the existing list of prohibited ingredients in cosmetics, this new list is subject to the following changes:
40 ingredients are revised, among which 2 ingredients exceptions were deleted, 2 are subject to name corrections and 36 are subject to revision of requirements.
255 ingredients are added to the list, among which 73 are ingredients only prohibited for use in hair dye products. In addition, Cannabidiol, which has received much attention in the global market, was added to the list.
Below ChemLinked lists some of the new prohibited ingredients. For the whole list of new prohibited ingredients and revised ingredients, please click the "Download" button at the bottom of the page.
No. in the list | Ingredient Name | CAS No. |
395 | Drosera peltata Sm. var. Multisepala Y. Z. Ruan (茅膏菜) | - |
396 | Skimmia reevesiana Fortune (茵芋) | - |
397 | Typhonium giganteum Engl. (白附子) | - |
398 | Sapium sebiferum (L.) Roxb. (烏桕) | - |
399 | Colchicin, its salts and derivatives | 64-86-8 |
400 | Hyoscyamine, its salts and derivatives | 101-31-5 |
401 | Hyoscine, its salts and derivatives | 51-34-3 |
402 | Cannabidiol | 13956-29-1 |
403 | Deanol aceglumate (INN) | 3342-61-8 |
404 | Spironolactone (INN) | 52-01-7 |
405 | [4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl] acetic acid (Tiratricol (INN)) and its salts | 51-24-1 |
406 | Methotrexate (INN) | 59-05-2 |
407 | Cinchophen (INN), its salts, derivatives and salts of these derivatives | 132-60-5/ 5949-18-8 |
408 | Thyropropic acid (INN) and its salts | 51-26-3 |
409 | Epinephrine (INN) | 51-43-4 |
410 | Isoprenaline (INN) | 7683-59-2 |
411 | Alloclamide (INN) and its salts | 5486-77-1 |
412 | Nalorphine (INN), its salts and ethers | 62-67-9 |
413 | Betoxycaine (INN) and its salts | 3818-62-0 |
414 | Zoxazolamine (INN) | 61-80-3 |
415 | Procainamide (INN), its salts and derivatives | 51-06-9 |
416 | Tuaminoheptane (INN), its isomers and salts | 123-82-0 |
417 | Octodrine (INN) and its salts | 543-82-8 |
418 | Isocarboxazid (INN) | 59-63-2 |
419 | Bendroflumethiazide (INN) and its derivatives | 73-48-3 |
420 | Bretylium tosilate (INN) | 61-75-6 |
421 | Carbromal (INN) | 77-65-6 |
422 | Bromisoval (INN) | 496-67-3 |
423 | Brompheniramine (INN) and its salts | 86-22-6 |
424 | Benzilonium bromide (INN) | 1050-48-2 |
425 | Tetrylammonium bromide (INN) | 71-91-0 |
426 | Tetracaine (INN) and its salts | 94-24-6 |
427 | Mofebutazone (INN) | 2210-63-1 |
428 | Tolbutamide (INN) | 64-77-7 |
429 | Carbutamide (INN) | 339-43-5 |
430 | Phenylbutazone (INN) | 50-33-9 |
431 | Phenprobamate (INN) | 673-31-4 |
432 | Chlorpropamide (INN) | 94-20-2 |
433 | Chlorzoxazone (INN) | 95-25-0 |
434 | Chlorprothixene (INN) and its salts | 113-59-7 |
435 | Clofenamide (INN) | 671-95-4 |
436 | Mannomustine (INN) and its salts | 576-68-1 |
437 | Butanilicaine (INN) and its salts | 3785-21-5 |
438 | Chlormezanone (INN) | 80-77-3 |
439 | Triparanol (INN) | 78-41-1 |
440 | Chlorphenoxamine (INN) | 77-38-3 |
441 | Phenaglycodol (INN) | 79-93-6 |
442 | Glycyclamide (INN) | 664-95-9 |
443 | Etc. |